Overview
Announcements

Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 2nd December 2024

Solactive China Healthcare Disruption Index:

In the ordinary adjustment, the following composition will be implemented effective open 2nd December 2024:

HUTCHMED CHINA LTD 0.4897 %
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 8.0 %
SIHUAN PHARMACEUTICAL HLDGS GRP ORD 0.1323 %
GRAND PHARMACEUTICAL GROUP LTD 0.3531 %
CHINA MEDICAL SYSTEM HOLDINGS LTD 0.3929 %
CSPC PHARMACEUTICAL GROUP LTD 8.0 %
SINO BIOPHARMACEUTICAL LTD ORD 8.0 %
SHANGHAI FUDAN-ZHANGJIANG BIO- 1.2682 %
LIVZON PHARMACEUTICAL GROUP INC 5.6316 %
GENSCRIPT BIOTECH CORP 4.205 %
YICHANG HEC CHANGJIANG PHA-H 0.1328 %
INNOVENT BIOLOGICS INC 8.0 %
SHANGHAI JUNSHI BIOSCIENCES CO LTD 4.6347 %
SIMCERE PHARMACEUTICAL GROUP 0.3786 %
LEPU BIOPHARMA CO LTD-H 0.1118 %
KEYMED BIOSCIENCES INC 0.2329 %
LUYE PHARMA GROUP LTD 0.2126 %
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 8.0 %
SHANGHAI MICROPORT MEDBOT GR 1.4666 %
WUXI BIOLOGICS CAYMAN INC 8.0 %
WUXI APPTEC CO LTD 8.0 %
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H 0.5 %
CHINA RESOURCES PHARMACEUTICAL 5.7941 %
HANSOH PHARMACEUTICAL GROUP CO 8.0 %
PHARMARON BEIJING CO LTD-H 0.5 %
AIM VACCINE CO LTD 0.0728 %
SKB BIO-B ORD H 0.4492 %
ZAI LAB LTD 0.4532 %
AKESO INC 8.0 %
ALPHAMAB ONCOLOGY 0.0978 %
REMEGEN CO LTD-H 0.3366 %
KANGJI MEDICAL HOLDINGS LTD 0.1537 %